Prosecution Insights
Last updated: April 19, 2026
Application No. 17/957,149

PARYLENE COATED NON-MEDICAL CONSUMER PRODUCTS

Non-Final OA §102§112
Filed
Sep 30, 2022
Examiner
DORNA, CARRIE R
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Voopray
OA Round
1 (Non-Final)
72%
Grant Probability
Favorable
1-2
OA Rounds
3y 5m
To Grant
99%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allow Rate
649 granted / 900 resolved
+2.1% vs TC avg
Strong +28% interview lift
Without
With
+28.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
35 currently pending
Career history
935
Total Applications
across all art units

Statute-Specific Performance

§101
5.7%
-34.3% vs TC avg
§103
37.2%
-2.8% vs TC avg
§102
21.3%
-18.7% vs TC avg
§112
25.7%
-14.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 900 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 1-6 and 12-17 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to nonelected inventions, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 12 March 2026. Applicant’s election without traverse of Invention II, claims 7-11 in the reply filed on 12 March 2026 is acknowledged. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 9-11 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 9 recites “a layer of parylene” while parent claim 7 recites “coated with parylene”. It is unclear whether the parylene of claim 9 is the same as that of the coating of claim 7. The same issue appears in claims 10 and 11. Claim 11 recites “the silicone components” yet previously recites “one or more silicone components. Since “one or more” encompasses one, at least one, or a plurality, it is unclear how many silicone component(s) applicant intends to reference and require. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 7-11 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by WO 2004/010906 (Forsell, see attached). Regarding claim 7, Forsell teaches an adult novelty item (device for treating impotence, pg. 2, lines 6-11; pg. 22, lines 22-26; Figure 1), comprising: a. an adult novelty substrate (12) (“tubular layer 12 of…hard silicone”, pg. 22, lines 26-34; Figure 2). Regarding claim 8, Forsell teaches the adult novelty item is a penis ring (pg. 2, lines 6-11; pg. 22, lines 22-26; Figure 1). Regarding claims 9 and 10, Forsell teaches a layer of parylene (14) is applied to the adult novelty substrate (12) at a location on the adult novelty substrate that is designed for contact with a human body and contact with a mucus membrane of the human body (parylene coating 14 makes “the composite structure resistant to aggressive body fluids and to give the composite structure good anti-friction properties”, pg. 7, line 34 – pg. 8, line 4; The limitations “for contact with a human body” and “for contact with a mucus membrane of the human body” are functional language. Forsell teaches the device is implanted, thus is in contact with a human body. Forsell teaches the parylene coating makes the structure “resistant to aggressive body fluids”, thus is configured for contact with a mucus membrane.). Regarding claim 11, Forsell teaches the adult novelty item including one or more silicone components (8, 10) (“tubular layer 8 of hard silicone”, “soft layer 10 of…silicone gel”, pg. 22, lines 26-34; Figure 2), wherein a layer of parylene (14) is applied to the silicone components (8, 10) thereby allowing the adult novelty item to be compatible with silicone lubricant (The limitation “allowing the adult novelty item to be compatible with silicone lubricant” is functional language. Since the parylene layer 14 is applied adjacent a silicone layer 12, the parylene-coated item 2 would be compatible with a silicone lubricant. See pg. 22, lines 26-34.). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Carrie R Dorna whose telephone number is (571)270-7483. The examiner can normally be reached 8am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Alexander Valvis can be reached at 571-272-4233. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CARRIE R DORNA/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Sep 30, 2022
Application Filed
Mar 24, 2026
Non-Final Rejection — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12582830
DEVICES, SYSTEMS AND METHODS FOR TREATING BACK PAIN WITH EMS
2y 5m to grant Granted Mar 24, 2026
Patent 12564727
SYSTEM AND METHOD FOR MULTI-COIL STEERABLE AND SELECTIVELY FOCUSSED TRANSCRANIAL MAGNETIC STIMULATION
2y 5m to grant Granted Mar 03, 2026
Patent 12558513
PATCH SYSTEM FOR MONITORING AND ENHANCING SLEEP AND CIRCADIAN RHYTHM ALIGNMENT
2y 5m to grant Granted Feb 24, 2026
Patent 12551325
Method of treating urinary incontinence in a patient by placing a sling in a single vaginal incision
2y 5m to grant Granted Feb 17, 2026
Patent 12527907
INTEGRATED STRONTIUM-RUBIDIUM RADIOISOTOPE INFUSION SYSTEMS
2y 5m to grant Granted Jan 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
72%
Grant Probability
99%
With Interview (+28.4%)
3y 5m
Median Time to Grant
Low
PTA Risk
Based on 900 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month